enVVeno Medical (NVNO) Financials

$9.09

$0.13 (1.45%)

As on 24-Sep-2026 16:00EDT

Market cap

$6 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.36	0.49	0.53	0.55	0.53	0.45
Gross Profit	-0.36	-0.49	-0.53	-0.55	-0.53	-0.45
Operating Expenses	16.52	20.90	23.30	24.69	24.41	16.44
Operating Profit (EBIT)	-16.75	-20.90	-23.83	-25.24	-24.93	-16.89
Other Income	--	--	--	--	0.10	--
Profit before Tax	-15.72	-19.47	-21.82	-23.52	-24.67	-16.53
Provision for Tax	--	--	--	--	-0.37	-0.33
Profit after Tax (Net Income)	-15.72	-19.47	-21.82	-23.52	-24.67	-16.53
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-24.67	-16.53

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	20.67	27.13	42.16	46.20	38.73	54.40
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.10	0.31	0.70	1.06	1.40	1.71
Current Liabilities	1.89	2.12	2.10	1.37	1.53	1.58
Total Liabilities	24.55	29.56	44.95	48.64	41.66	57.70

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.58	0.74	1.22	1.71	2.23	2.66
Current Assets	22.08	28.83	43.73	46.92	39.44	55.04
Total Assets	24.55	29.56	44.95	48.64	41.66	57.70
Total Debt*	0.51	0.70	1.06	1.40	1.72	2.01
Net Current Assets	20.20	26.70	41.64	45.55	37.91	53.46

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-15.57	-16.84	-18.86	-15.62	-11.85
Cash Flow from Investing Activities	--	15.86	1.34	-7.87	-34.55	-0.37
Cash from Financing Activities	--	1.02	13.64	25.79	0.00	57.61
Net Cash Inflow / Outflow	--	--	--	--	-50.17	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-512.77	-1,180.12	-1,314.40	-2,157.43	-3,203.77	-1,816.24
Cash EPS ($)	--	-1,150.48	-1,282.59	-2,107.71	-3,135.58	-1,766.47
Adjusted Book Value ($)	--	1,644.24	2,539.70	4,238.53	5,029.74	5,978.48
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-943.52	-1,014.34	-1,730.09	-2,028.44	-1,301.98
Free Cash Flow per Share ($)	--	-943.82	-1,016.57	-1,733.12	-2,043.38	-1,342.42

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-54.81	-48.05	-53.42	-50.94	-51.34
ROE (%)	-65.79	-56.21	-49.39	-55.38	-52.98	-53.75
ROA (%)	-49.03	-52.26	-46.63	-52.09	-49.66	-48.44
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-24,185.29	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	30.06	10.76	7.22	4.67	-49.26	-80.92
Net Profit Growth (%)	31.84	10.76	7.22	4.67	-49.26	-80.92
EPS Growth (%)	65.36	0.10	0.39	0.33	-0.76	0.58
Book Value Growth (%)	-98.45	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	0.00	0.00	0.00	0.00	0.00
Price / Book Value	0.30	0.00	0.00	0.00	0.00	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.87	1.45	1.97	1.96	1.54	3.28
Close Price ($)	10.71	11.23	105.70	179.90	178.50	230.65
High Price ($)	196.70	196.70	243.95	227.15	277.55	398.30
Low Price ($)	8.67	10.54	85.75	87.85	117.25	174.65
Market Cap ($ Cr)	6.24	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.03	0.03	0.03	0.04	0.04
Short term debt to equity ratio	0.02	0.01	0.01	0.01	0.01	0.01
Current Ratio	11.70	13.58	20.88	34.23	25.78	34.83
Quick Ratio	11.70	--	--	--	--	--
Interest Coverage	--	--	--	--	-93.80	-883.42

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	509.41	495.65	359.56	420.24	786.47
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.